http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111171009-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 |
| filingDate | 2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111171009-B |
| titleOfInvention | Entrectinib crystal form and preparation method thereof |
| abstract | The present invention provides a crystal form of entrectinib and a preparation method thereof. Specifically, the present invention provides the crystal form of the compound shown in formula I, and the crystal form is crystal form AZT-A, crystal form AZT-B or crystal form AZT-E. Compared with the existing entrectinib crystal form, the crystal form of the present invention has more excellent solubility, better stability, updated electrostatic effect, simple preparation process, strong operability, high yield, stable quality and short production cycle , easy to achieve large-scale production. |
| priorityDate | 2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.